￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
The effect of ceritinib in the treatment of ALK-positive metastatic non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Can the lung cancer-targeted drug Gitairi be reimbursed by medical insurance?

2025-10-19 11:44:20

Check Details
The price of the targeted drug ceritinib after medical insurance reimbursement

2025-10-19 11:44:20

Check Details
How long can you live with cabozantinib treatment for advanced lung cancer?

2025-10-19 11:44:20

Check Details
When will Giterab (afatinib) be included in medical insurance?

2025-10-19 11:44:20

Check Details
Analysis of the efficacy and toxic side effects of ceritinib in the treatment of ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Is the targeted drug Giteri (afatinib) a drug reimbursed by medical insurance?

2025-10-19 11:44:20

Check Details
How much will the out-of-pocket cost of ceritinib be after entering the medical insurance?

2025-10-19 11:44:20

Check Details
How long does it take for lung cancer to develop resistance to cabozantinib?

2025-10-19 11:44:20

Check Details
What drug is ceritinib? What condition is treated?

2025-10-19 11:44:20

Check Details
Is Giteri (afatinib) included in medical insurance this year?

2025-10-19 11:44:20

Check Details
Patient Information: Precautions when Using Cabozantinib to Treat Lung Cancer - Kanghule

2025-10-19 11:44:20

Check Details
Category
相关知识